Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,321 recruiting studies in this area right now.
By phase
- Not applicable4,386
- Phase 2608
- Phase 1414
- Phase 3321
- Phase 4268
- Phase 1/Phase 2254
- Phase 2/Phase 370
Top conditions
- Ovarian Cancer340
- Cervical Cancer232
- Endometrial Cancer206
- Bladder Cancer192
- Acute Kidney Injury136
- Endometriosis135
- Pregnancy132
- Chronic Kidney Diseases131
- Breast Cancer107
- Chronic Kidney Disease104
- Infertility95
- Renal Cell Carcinoma80
- Colorectal Cancer76
- Preeclampsia73
- Pregnancy Related72
- Prostate Cancer65
- Urinary Incontinence64
- Lung Cancer63
Leading sponsors
- Mayo Clinic58
- Assistance Publique - Hôpitaux de Paris47
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS47
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- National Cancer Institute (NCI)40
- University of Colorado, Denver39
- Chinese University of Hong Kong38
- University of Aarhus36
- AstraZeneca34
Where studies are running
- California345
- Alabama155
- Texas122
- Massachusetts119
- New York118
- Florida102
- Arizona100
- Colorado90
- Maryland90
- Illinois78
Recruiting studies6,321 total
- NCT06211348Recruiting
Genomic sequencing for healthy-looking fetuses
This study looks at the benefits of doing extra genetic testing (genomic sequencing) on samples from routine prenatal tests like CVS or amniocentesis, specifically for pregnancies where the baby appears normal on ultrasound.
San Francisco, CaliforniaAges 18–64 - NCT06433609RecruitingPhase 2
ADC plus immunotherapy for advanced HER2-negative breast cancer
This trial tests a combination of an antibody-drug conjugate (ADC) and an immunotherapy drug (adebrelimab) for people with advanced HER2-negative breast cancer that has stopped responding to prior treatments. The goal is to see if this combination can help shrink or slow the cancer.
Beijing, Beijing MunicipalityAges 18–75 - NCT06212102RecruitingPhase 2
Comparing two drugs for poor responders in double ovarian stimulation
This trial compares dydrogesterone with a GnRH antagonist to see which works better for women with a low number of eggs (poor responders) who are undergoing two rounds of egg retrieval in one cycle. It may help improve outcomes for those with specific fertility challenges.
Cairo, Cairo GovernorateAges 35–44 - NCT07736859Enrolling by invitation
A study on foam ultrasound for fertility evaluation
This study looks at how satisfied women are with a special ultrasound test (HyFoSy) that uses foam to check the fallopian tubes and uterus as part of a fertility workup. It aims to learn if this method is comfortable and helpful for patients.
NancyAges 18 years+ - NCT06187675Recruiting
Nutrition and exercise program with choice for pregnancy
This study tests a program where you can choose your own nutrition and exercise plan during pregnancy. It aims to see if giving you options helps you and your baby stay healthy.
London, OntarioAges 18 years+ - NCT06186271Recruiting
Safety of Estetrol Birth Control Pill Study
This study checks the safety of a newer birth control pill (E4/DRSP) compared to other common pills. It is for women who are just starting one of these pills.
Berlin, State of BerlinAges Any age - NCT07287280Recruiting
Predicting surgery complications in gynecologic cancer
This study is comparing two different tools that doctors use to predict complications from gynecologic cancer surgery. The goal is to see which tool works better for planned (non-emergency) surgeries.
BangkokAges 18 years+ - NCT05575804RecruitingPhase 1/Phase 2
GQ1001 plus pyrotinib for HER2-positive metastatic breast cancer
This trial tests a combination of two targeted drugs, GQ1001 and pyrotinib, for people with HER2-positive breast cancer that has spread to other parts of the body and has not responded to at least one prior treatment. The goal is to see if this combination can shrink tumors or slow cancer growth.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07295054RecruitingPhase 4
Inhaled pain relief for IUD insertion
This trial tests a drug called methoxyflurane, which you inhale through a small handheld device, to see if it reduces pain during IUD insertion. It may be an option for people who want extra pain control during the procedure.
Toronto, OntarioAges 18–55 - NCT06165367Recruiting
Does hyaluronan in the medium improve embryo transfer success?
This trial tests if adding hyaluronan to the liquid used during embryo transfer helps increase the chance of a successful pregnancy. It is for women who have at least one genetically normal embryo (tested with PGT-A) that was frozen on day 5 and are using hormone replacement therapy to prepare the uterus.
Abu Dhabi, Abu Dhabi EmirateAges 18–46 - NCT07286240RecruitingPhase 2
QL1706 with chemo and anlotinib for recurrent ovarian cancer
This trial tests a combination of a new immunotherapy drug (QL1706), chemotherapy, and a targeted therapy (anlotinib) for ovarian cancer that has come back after standard platinum treatment. The goal is to see if this triple therapy can shrink tumors or slow the cancer's return.
Guangzhou, GuangdongAges 18–70 - NCT06158126RecruitingPhase 4
Pregnancy and infant health outcomes study
This study follows pregnant women and their babies to see how well HIV prevention medicines work during pregnancy. It aims to help keep both mother and baby healthy.
LilongweAges 15–55 - NCT06088537Recruiting
Blood in newborn stool: allergy or temporary colitis?
This study looks at very young babies (less than a month old) who have blood in their stool but are otherwise well. The goal is to find out whether the bleeding is due to a food allergy or a short-term gut irritation, so doctors can give the right care.
Nice, Alpes-MritimesAges 1 day–4 weeks - NCT06147388Recruiting
Can cervical precancer heal on its own?
This study watches to see if early precancerous cells (CIN 2 or 3) on the cervix can go away without treatment, especially in women under 40. It helps doctors understand who might avoid surgery.
PragueAges 18–40 - NCT06142656RecruitingPhase 2/Phase 3
Vildagliptin vs Metformin for PCOS
This trial compares two medicines, vildagliptin and metformin, to see which works better for women with Polycystic Ovary Syndrome (PCOS). The goal is to find a safe and effective treatment that may help manage PCOS symptoms.
GizaAges 18–50 - NCT07204795Recruiting
Carbohydrate drink before planned C-section
This study tests if drinking a sugary drink before a planned C-section improves recovery. It may help women feel better after surgery.
ErzurumAges 18 years+ - NCT07244354Enrolling by invitation
Maternal warmth after C-section and recovery
This study looks at whether keeping mothers warm after a C-section helps them recover faster. It compares standard care with a warmer blanket to see if it reduces shivering and improves comfort.
Oslo, OsloAges 18–50 - NCT06141447RecruitingPhase 2
Study on oxytocin to reduce bleeding during D&E
This trial tests if giving oxytocin before a dilation and evacuation (D&E) procedure helps reduce bleeding. It may help people scheduled for a D&E at 18 weeks or later.
Denver, ColoradoAges 18–55 - NCT06139458Recruiting
Cooling therapy to prevent nerve damage from chemo
This trial tests if cooling sleeves and gloves during chemotherapy can help prevent nerve damage (peripheral neuropathy) in people with gynecologic cancers. If you are receiving a common chemo drug called paclitaxel, this approach might reduce side effects like numbness or pain in your hands and feet.
Hartford, ConnecticutAges 18 years+ - NCT06130371Recruiting
Stress, Inflammation & Brain in Depression vs. Severe PMS
This study looks at how stress and inflammation affect the brain in women with major depression compared to women with severe PMS (PMDD). It could help find better ways to understand and treat these mood disorders.
Tübingen, Baden-WurttembergAges 18–40 - NCT07062978RecruitingPhase 3
Comparing QL1206 to Prolia for postmenopausal osteoporosis
This trial tests a new medication, QL1206, against an approved drug, Prolia, to see if it works as well for treating osteoporosis in postmenopausal women. You may be eligible if you have low bone density and at least one risk factor for fractures.
GuizhouAges 50–85 - NCT07011563Recruiting
Helping teens & adults talk about sexual health
This study helps teens and their trusted adults have open conversations about sexual health. It's for young people ages 14 to 17 who have had oral or anal sex with another male.
Providence, Rhode IslandAges 14–17 - NCT04804332Recruiting
Hysteroscopy to remove leftover tissue after miscarriage
This trial studies the best way to remove leftover pregnancy tissue after a first-trimester miscarriage. It compares approaches guided by a camera procedure in the uterus to see which helps most, especially for people who want to get pregnant again soon.
GhentAges 18–39 - NCT06114199Recruiting
Home-delivered produce program for high-risk pregnancy
This trial tests a program that delivers fresh fruits and vegetables to your home during pregnancy. It’s for people at high-risk clinics who want to see if eating better can improve their health.
Houston, TexasAges 18–44
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,321 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 10,245 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.